M.D. Anderson Cancer Center: all 3,044 studies

Page 19 of 31. Open to participants first (578), then studies with results posted, then the rest; newest registration first within each.

• Binimetinib and Hydroxychloroquine in Treating Patients With KRAS Mutant Metastatic Pancreatic CancerCompletedNCT04132505Phase 1
• Patient and Physician Perspectives on Non-Alcoholic Fatty Liver DiseaseActive, not recruitingNCT04132440
• Patient and Caregiver Attitudes and Beliefs Regarding Prescription of Intranasal Naloxone Spray for Opioid OverdoseActive, not recruitingNCT04129138
• Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic SyndromeActive, not recruitingNCT04128748Phase 1/2
• Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant SettingActive, not recruitingNCT04128501Phase 2
• Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell TransplantationWithdrawnNCT04127721Phase 2
• Weight Management and Health Behavior Intervention in Lowering Cancer Risk for BRCA Positive and Lynch Syndrome FamiliesActive, not recruitingNCT04125914Not applicable
• Cordotomy in Reducing Pain in Patients With Advanced CancerActive, not recruitingNCT04119037Not applicable
• Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine CancersWithdrawnNCT04106843Phase 2
• Effect of EHealth Coaching Program on Patient Reported Outcomes of Men With Prostate CancerCompletedNCT04106245Not applicable
• Frequency of Cachexia in Ambulatory Cancer Patients and Psychological Burden in Patients and Their Primary CaregiversActive, not recruitingNCT04090619
• Barriers Associated With Timely Adjuvant Chemotherapy Administration in Patients With Invasive Breast CancerCompletedNCT04087057
• nTMS in Planning Stereotactic Radiosurgery in Patients With Brain Metastases in the Motor CortexActive, not recruitingNCT04062305Not applicable
• AZA + Venetoclax as Maintenance Therapy in Patients With AML in RemissionTerminatedNCT04062266Phase 2
• Pembrolizumab and PEGPH20 in Treating Patients With Metastatic Pancreatic CancerWithdrawnNCT04058964Phase 2
• PAT-1251 in Treating Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocytosis MyelofibrosisWithdrawnNCT04054245Phase 2
• Ultra Low Dose Radiation Delivered Before or After Chemotherapy-Free Targeted Therapy in Treating Patients With Relapsed or Refractory Mantle Cell LymphomaActive, not recruitingNCT04054167Phase 2
• An Investigational Device (Millar Mikro-Tip Catheter) and Imaging Scan (Shear Wave Elastography) in Measuring Tumor Pressure and Stiffness in Patients With Solid Tumors Undergoing Ultrasound-Guided BiopsyCompletedNCT04054154Not applicable
• Financial Distress in Advanced Cancer PatientsActive, not recruitingNCT04053517
• Nutritional Supplementation in Reducing Complications in Patients With Locally Advanced Esophageal Cancer Undergoing Chemotherapy, Radiation Therapy, and/or SurgeryWithdrawnNCT04029857Phase 3
• Modified Immune Cells (CD19-CD22 CAR T Cells) in Treating Patients With Recurrent or Refractory CD19 Positive, CD22 Positive Leukemia or LymphomaWithdrawnNCT04029038Phase 1/2
• PLX51107 and Azacitidine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeCompletedNCT04022785Phase 1
• Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast CancerCompletedNCT04022772Not applicable
• An Investigational Scan (Magnetic Resonance Elastography) in Detecting Treatment Response in Patients With Advanced Liver CancerCompletedNCT04022746Not applicable
• Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal CancerActive, not recruitingNCT04017650Phase 1/2
• Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small Lung CancerActive, not recruitingNCT04013542Phase 1
• Quit4Health Intervention in Supporting Smoking Cessation and Preventing Smoking Initiation in Young AdultsCompletedNCT04009590Not applicable
• CT Perfusion Scans in Detecting Changes in Blood Flow to the Liver After Portal Vein EmbolizationStatus unknownNCT03990623Not applicable
• An Investigational Surgical Procedure (Vascularized Lymph Node Transfer) in Reducing the Risk of Lymphedema in Patients With Breast Cancer Undergoing Breast ReconstructionActive, not recruitingNCT03990610Not applicable
• StrataXRT in Preventing Radiation Dermatitis in Pediatric Patients Undergoing Radiation Therapy to the Brain or Spinal CordWithdrawnNCT03990597Phase 1
• Itacitinib and Alemtuzumab in Treating Patients With T-Cell Prolymphocytic LeukemiaCompletedNCT03989466Phase 1
• Survey of Cancer Patients' Perceptions of Difficulties Encountered When Filling Opioid PrescriptionsStatus unknownNCT03989128
• Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate CancerActive, not recruitingNCT03987386Phase 3
• Ultrasound in Evaluating Muscle-Glycogen Content in Cancer PatientsCompletedNCT03982082Not applicable
• New Magnetic Resonance Imaging and Spectroscopy Software in the Improvement of Image QualityCompletedNCT03980535Not applicable
• Time From Onset of Fever to Administration of Antibiotics in Neutropenic Fever PatientsCompletedNCT03968328
• An Investigational Scan (MRI) in Imaging Patients With Newly-Diagnosed or Recurrent ThymomaActive, not recruitingNCT03968315Not applicable
• PET/MR Versus CECT Scans in Imaging Patients With Ovarian Cancer or Highly Suspected Ovarian CancerActive, not recruitingNCT03965481Not applicable
• Resting-State Functional MRI in Glioma Patients Before and After SurgeryCompletedNCT03964909Not applicable
• Nurse-Driven Telephone Intervention in Improving Side Effects in Cancer Patients Undergoing ChemotherapyCompletedNCT03964896Not applicable
• Gallium Ga 68-DOTATATE PET/CT in Predicting Tumor Growth in Patients With MeningiomasCompletedNCT03953131Phase 1
• Dietary Intervention in Patients with a History of MelanomaTerminatedNCT03950635Phase 1
• Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid TumorsActive, not recruitingNCT03950609Phase 2
• Venetoclax and Acalabrutinib in Treating Patients With Relapsed or Refractory Mantle Cell LymphomaActive, not recruitingNCT03946878Phase 2
• Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before SurgeryActive, not recruitingNCT03943173Early Phase 1
• Correlating MicroRNA Changes With Sepsis OutcomesActive, not recruitingNCT03929159
• Open Labeled Placebo in Reducing Cancer Related Fatigue in Patients With Advanced CancerActive, not recruitingNCT03927885Phase 2/3
• F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing SurgeryCompletedNCT03926507Not applicable
• Radioembolization for HCC Patients With Personalized Yttrium-90 Dosimetry for Curative Intent (RAPY90D)Active, not recruitingNCT03896646Not applicable
• Clinical Data Collection in Studying Clinical Factors Associated With Post-Surgery Chronic Opioid Use in Patients With Head and Neck CancersActive, not recruitingNCT03888651
• Trabectedin and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Resistant or Intolerant to a BTK InhibitorWithdrawnNCT03884972Phase 1
• Rapid On Site Evaluation of Pleural Touch Preparations in Diagnosing Malignant Pleural Effusion in Patients Undergoing PleuroscopyCompletedNCT03868579Not applicable
• Fluciclovine F18 PET/CT in Identifying the Origin of Head and Neck Squamous Cell Carcinoma in Patients With Metastatic Cervical Nodal DiseaseCompletedNCT03868020Early Phase 1
• Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaActive, not recruitingNCT03862157Phase 1/2
• Fecal Transplant +/- Gut Decontamination in Preventing Acute Graft Versus Host Disease in Patients Given Broad-Spectrum AntibioticsWithdrawnNCT03862079Phase 2
• Videos and Questionnaires in Assessing Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic VisitsCompletedNCT03856060Not applicable
• Circulating Cell-Free Tumor DNA Testing in Guiding Treatment for Patients With Advanced or Metastatic Colorectal CancerActive, not recruitingNCT03844620Phase 2
• Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate CancerActive, not recruitingNCT03821792Phase 2
• Shorter Course, Hypofractionated Pre-Surgery Radiation Therapy in Treating Patients With Localized, Resectable Soft Tissue Sarcoma of the Extremity of Superficial TrunkActive, not recruitingNCT03819985Phase 2
• Effectiveness of an Online Intervention Targeting Cancer-related FatigueTerminatedNCT03809130Not applicable
• Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic LeukemiaTerminatedNCT03808610Phase 1/2
• A Phase I Study of SOR-C13 in Patients With Advanced Solid TumorsCompletedNCT03784677Phase 1
• Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal and Gastroesophageal AdenocarcinomaActive, not recruitingNCT03784326Phase 2
• Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric CancerActive, not recruitingNCT03776487Phase 2
• Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate CancerActive, not recruitingNCT03772834Phase 2/3
• Nivolumab and Ibrutinib in Treating Patients With Relapsed or Refractory Central Nervous System LymphomaCompletedNCT03770416Phase 2
• Daratumumab, Bortezomib, and Dexamethasone Followed by Daratumumab, Ixazomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple MyelomaActive, not recruitingNCT03763162Phase 2
• TAK-659 and Paclitaxel in Treating Patients With Advanced Solid TumorsCompletedNCT03756818Phase 1
• TK216 and Decitabine in Treating Patients With Relapsed and Refractory Acute Myeloid LeukemiaWithdrawnNCT03752138Phase 1
• Cognitive Behavioral Therapy in Helping Patients With Acute Myeloid Leukemia or Lymphoma With Cancer-Related FatigueActive, not recruitingNCT03747757Phase 2
• Pemetrexed and Avelumab in Treating Patients With MTAP-Deficient Metastatic Urothelial CancerActive, not recruitingNCT03744793Phase 2
• Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative CareActive, not recruitingNCT03743649Phase 2/3
• Pre-operative SRS or Post-operative SRS in Treating Cancer Patients With Brain MetastasesActive, not recruitingNCT03741673Phase 3
• Online Psychosocial Intervention in Improving Social Well-Being and Support in Women With Stage I-IV Non-small Cell Lung Cancer Undergoing TreatmentActive, not recruitingNCT03731585Not applicable
• ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid TumorsCompletedNCT03725436Phase 1
• Ibrutinib, Rituximab, Venetoclax, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell LymphomaActive, not recruitingNCT03710772Phase 2
• Local Consolidative Therapy and Brigatinib in Treating Patients With Stage IV or Recurrent Non-small Cell Lung CancerActive, not recruitingNCT03707938Phase 1
• ADCT-602 in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic LeukemiaTerminatedNCT03698552Phase 1/2
• DECT in Imaging Patients With Solid Organ Cancer With Intracranial MetastasisCompletedNCT03685539Not applicable
• Ultra Low-Dose Radiation Therapy in Treating Patients With Stage I-IV Stomach MALT LymphomaActive, not recruitingNCT03680586Early Phase 1
• Electronic Neurocognitive Tools in Screening for Mental Capability in Patients Undergoing Liver SurgeryActive, not recruitingNCT03678441Not applicable
• Patients Navigators in Facilitating Weight Management in Obese ParticipantsActive, not recruitingNCT03674229Not applicable
• Liposome-encapsulated Daunorubicin-Cytarabine and Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic SyndromeCompletedNCT03672539Phase 2
• Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care CenterActive, not recruitingNCT03671226Not applicable
• Tailored Smoking Cessation Intervention in Promoting Sexual and Gender Minority Smokers to Quit SmokingCompletedNCT03669120Not applicable
• Quitting Schedule Mobile Smartphone Application in Helping Participants to Quit SmokingWithdrawnNCT03668769Not applicable
• Survey of Post-Acute Inpatient Rehabilitation Safety Concerns in Participants With CancerCompletedNCT03656224
• Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung CancerActive, not recruitingNCT03637816Phase 2/3
• MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal CancerTerminatedNCT03634267Phase 1
• Personalized Vaccine in Treating Patients With Smoldering Multiple MyelomaCompletedNCT03631043Early Phase 1
• Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell TransplantActive, not recruitingNCT03622788Phase 1/2
• M7824 in Treating Patients With Stage II-III HER2 Positive Breast CancerCompletedNCT03620201Phase 1
• Navigated Repetitive Transcranial Magnetic Stimulation in Improving Motor Rehabilitation in Participants With Brain TumorsActive, not recruitingNCT03606161Not applicable
• Recombinant Human Interleukin-7 (CYT107) to Promote T-Cell Recovery After Cord Blood TransplantationWithdrawnNCT03600896Phase 1/2
• Nivolumab and Ipilimumab After Donor Stem Cell Transplant in Treating Patients With High Risk Refractory or Relapsed Acute Myeloid Leukemia or Myelodysplastic SyndromeCompletedNCT03600155Phase 1
• Systemic Therapy With or Without Local Consolidative Therapy in Treating Patients With Oligometastatic Solid TumorActive, not recruitingNCT03599765Phase 2
• Chemotherapy and/or Metastasectomy in Treating Patients With Metastatic Colorectal Adenocarcinoma With Lung MetastasesActive, not recruitingNCT03599752Phase 2
• Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory OsteosarcomaActive, not recruitingNCT03598595Phase 1/2
• Rectal Administration of Opioids Using the Macy Catheter in Reducing Pain in Patients With Advanced CancerWithdrawnNCT03592459Not applicable
• Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney CancerCompletedNCT03587662Phase 2

← M.D. Anderson Cancer Center overview and focus areas